baumannii to cefoperazone-sulbactam (from 40.6% to 52.8%) and piperacillin-tazobactam (from 64.5% to 73.2%), while a decreasing trend was observed in resistance to tigecycline (from 10.3% to 2.8%) and minocycline (from 30.4% to 21.0%) ( Figure 7 ).
← all excerpts
ESKAPE in China: epidemiology and characteristics of antibiotic resistance.
2
—
—
The sentences
It is noteworthy that, despite its lower prevalence, the ST398 clone has shown an increasing trend; as reported, an increase in the isolation rate of the ST398 clone from 1.47% in 2014 to 9.14% in 2019 [ 49 , 69 ].